PD357 300 (Rezulin 300 mg)
Generic Name: troglitazone
Pill imprint PD357 300 has been identified as Rezulin 300 mg.
Rezulin is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Rezulin (troglitazone)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.